PEREGRINE PHARMACEUTICALS IN's ticker is PPHMXXXX and the CUSIP is 713661304. A total of 74 filers reported holding PEREGRINE PHARMACEUTICALS IN in Q1 2014. The put-call ratio across all filers is 1.57 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $116,000 | -7.2% | 190,991 | 0.0% | 0.00% | – |
Q1 2017 | $125,000 | +111.9% | 190,991 | 0.0% | 0.00% | – |
Q4 2016 | $59,000 | -28.0% | 190,991 | 0.0% | 0.00% | – |
Q3 2016 | $82,000 | +17.1% | 190,991 | 0.0% | 0.00% | – |
Q2 2016 | $70,000 | -12.5% | 190,991 | 0.0% | 0.00% | – |
Q1 2016 | $80,000 | -64.1% | 190,991 | 0.0% | 0.00% | – |
Q4 2015 | $223,000 | +14.4% | 190,991 | 0.0% | 0.00% | – |
Q3 2015 | $195,000 | -47.0% | 190,991 | -32.1% | 0.00% | -100.0% |
Q2 2015 | $368,000 | -3.2% | 281,291 | 0.0% | 0.00% | 0.0% |
Q1 2015 | $380,000 | -2.8% | 281,291 | 0.0% | 0.00% | 0.0% |
Q4 2014 | $391,000 | +2.1% | 281,291 | 0.0% | 0.00% | 0.0% |
Q3 2014 | $383,000 | -27.6% | 281,291 | 0.0% | 0.00% | 0.0% |
Q2 2014 | $529,000 | -0.9% | 281,291 | 0.0% | 0.00% | -50.0% |
Q1 2014 | $534,000 | +36.6% | 281,291 | 0.0% | 0.00% | +100.0% |
Q4 2013 | $391,000 | +0.8% | 281,291 | +2.3% | 0.00% | 0.0% |
Q3 2013 | $388,000 | -5.8% | 274,839 | -13.9% | 0.00% | 0.0% |
Q2 2013 | $412,000 | – | 319,239 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BAXTER BROS INC | 170,506 | $232,000 | 0.09% |
First Heartland Consultants, Inc. | 86,204 | $117,000 | 0.05% |
Rotella Capital Management, Inc. | 20,769 | $28,000 | 0.03% |
FIDGEON TIMOTHY F | 33,000 | $45,000 | 0.02% |
QS BATTERYMARCH FINANCIAL MANAGEMENT, INC | 547,800 | $746,000 | 0.02% |
Freedom Investment Management, Inc. | 74,127 | $101,000 | 0.02% |
Investors Capital Advisory Services | 63,288 | $86,000 | 0.02% |
REYNOLDS CAPITAL MANAGEMENT LLC | 10,000 | $14,000 | 0.01% |
Tower Research Capital LLC (TRC) | 76,914 | $104,000 | 0.01% |
PINNACLE FINANCIAL PARTNERS INC | 20,000 | $27,000 | 0.01% |